Advances in the Management of Difficult-to-Treat Asthma

Program Overview

The management of severe asthma has changed drastically after the introduction of biologics. However, their introduction comes with many questions, such as, When should they be used and in whom? This Care Team Forum^SM brings pulmonologists and an allergist/immunologist in dialogue with a patient about the immunologic underpinning of asthma pathology and how it relates to identifying patients appropriate for step-up care with biologics.

Credit Expired

Target Audience

The target audience for this activity is US-based pulmonologists, allergists, and immunologists, as well as NPs and PAs who diagnosis and manage difficult-to-treat and severe asthma.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Distinguish between the different types of asthma based on underlying pathophysiology and biomarkers of disease in order to make personalized treatment decisions
Identify patients with poorly-controlled or difficult-to-treat asthma who are eligible for step-up therapies, including new and emerging biologics
Incorporate new and emerging targeted biologics into the management of patients with severe or poorly-controlled asthma when appropriate

Activity Faculty

Reynold A. Panettieri, Jr, MD

Professor of Medicine, Robert Wood Johnson Medical School
Vice Chancellor, Clinical & Translational Science
Director, Rutgers Institute for Translational Medicine & Science
Emeritus Professor, Medicine
Rutgers University
New Brunswick, NJ

Michael E. Wechsler, MD, MMSc

Co-Director, The Cohen Family Asthma Institute
Professor, Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Denver, CO

Jonathan Corren, MD

Clinical Associate Professor, Medicine and Pediatrics Division of Clinical Immunology and Allergy
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA

Featured RMEI CE Activities

Advances in the Management of Difficult-to-Treat Asthma

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Reynold A. Panettieri, Jr, MD

Michael E. Wechsler, MD, MMSc

Jonathan Corren, MD

Patient Perspectives in Food Allergy: Advances in Treatment Strategies to Address Unmet Needs

Bolstering the Bronchi: Emerging Therapeutic Strategies for Patients with NCFBE

Targeted Approaches to CMV Management: Alleviating the Patient Burden from Prevention to Refractory Disease

Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®

Company

Subscribe